Advanced Catheter Therapies
11 known investors
Find your way into Advanced Catheter Therapies
Sign up to see every warm intro you have to Advanced Catheter Therapies
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Advanced Catheter Therapies team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Advanced Catheter Therapies develops the Pressana Occlusion Perfusion Catheter, a medical device for targeted endovascular delivery of therapeutic agents to treat peripheral arterial disease and prevent limb amputation. The device is FDA-cleared for below-the-knee use and enables localized infusion of various physician-prescribed medications to prevent restenosis after vessel modification procedures.
Founders & leadership
Investors · 11
How we know: Chattanooga Renaissance Fund's portfolio page · finance.yahoo.com · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Innova Memphis, Inc.'s portfolio page · the VCSheet dataset · Not right? Tell us
Also in the syndicate · 7
Funding
SEC filings, press & company announcements- Undisclosed amountSeries BMar 2015
Toray Industries, Inc.
Source ↗ - Undisclosed amountSeries BAug 2014
ACT I Investments, LLC, Blank Slate Venture Fund II, LLC, Chattanooga Renaissance Fund, DeMoss Alternative Opportunities Fund, LP, INCITE Co-Investment Fund, Innova Fund II LP, Maclellan Foundation
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Related companies · 5
Companies working in the same space as Advanced Catheter Therapies.
In the news
Frequently asked questions
- What does Advanced Catheter Therapies do?
- Advanced Catheter Therapies develops the Pressana Occlusion Perfusion Catheter, a medical device for targeted endovascular delivery of therapeutic agents to treat peripheral arterial disease and prevent limb amputation. The device is FDA-cleared for below-the-knee use and enables localized infusion of various physician-prescribed medications to prevent restenosis after vessel modification procedures.
- Who are Advanced Catheter Therapies's investors?
- Advanced Catheter Therapies's investors include Chattanooga Renaissance Fund, Innova Memphis, Inc., Solas BioVentures, Blank Slate Ventures.


